Table 2.
Experiment 1: Morphometric and biochemical data for male DR rats injected at 4 wk of age with AAV control shRNA or AAV CTR shRNA in the VMH
Sham | AAV Control | AAV CTR | |
---|---|---|---|
6-wk chow | |||
Initial body weight, g | 87.6 ± 4.2 | 89.8 ± 3.8 | 84.4 ± 5.7 |
Body weight chow, g | 306 ± 8 | 301 ± 12 | 287 ± 14 |
Body weight gain on chow, g | 218 ± 9 | 212 ± 9 | 202 ± 11 |
Food intake on chow, kcal | 2,629 ± 42 | 2,619 ± 110 | 2,505 ± 135 |
Feed efficiency on chow, BWG (g)/FI (kcal) × 1,000 | 83 ± 3 | 81 ± 3 | 81 ± 3 |
Leptin, ng/ml | 5.14 ± 0.9a | 7.64 ± 0.89a | 15.8 ± 2.43b |
Glucose, mg/dl | 137.63 ± 1.75 | 137.94 ± 7.46 | 138.69 ± 3.25 |
Insulin, ng/ml | 0.80 ± 11a | 1.05 ± 0.10a | 1.85 ± 0.13b |
6-wk 45% fat diet | |||
Body weight gain, g | 126 ± 9a | 131 ± 18a | 168 ± 13b |
Food intake, kcal | 1,594 ± 39 | 1,560 ± 72 | 1,613 ± 87 |
Feed efficiency, BWG (g)/FI (kcal) × 1,000 | 33 ± 1 | 35 ± 3 | 39 ± 5 |
Total 6-wk chow, 6-wk 45% fat diet | |||
Final body weight, g | 435 ± 14 | 433 ± 25 | 459 ± 23 |
Total body weight gain, g | 347 ± 18 | 343 ± 23 | 375 ± 23 |
Total food intake, kcal | 6,488 ± 173 | 6,310 ± 312 | 6,609 ± 370 |
Feed efficiency total, BWG (g)/FI (kcal) × 1,000 | 53 ± 1 | 54 ± 2 | 54 ± 3 |
Retroperitoneal, g | 9.28 ± 0.78a | 10.52 ± 0.79a | 13.87 ± 1.22b |
Retroperitoneal, %BW | 2.15 ± 0.17a | 2.43 ± 0.12a,b | 3.00 ± 0.22b |
Mesenteric, g | 7.79 ± 1.45a | 8.39 ± 0.81a | 15.0 ± 1.7b |
Mesenteric, %BW | 1.79 ± 0.16a | 1.94 ± 0.17a | 3.31 ± 0.31b |
Inguinal, g | 6.47 ± 0.68a | 8.77 ± 1.01a | 16.89 ± 1.03b |
Inguinal, %BW | 1.81 ± 0.34a | 2.05 ± 0.25a | 3.35 ± 0.28b |
Epididymal, g | 9.38 ± 0.66 | 11.0 ± 1.3 | 16.0 ± 1.7 |
Epididymal, %BW | 2.18 ± 0.15a | 2.53 ± 0.20a | 3.75 ± 0.34b |
Perirenal, g | 3.50 ± 0.12 | 4.05 ± 0.52 | 5.70 ± 0.68 |
Perirenal, %BW | 0.81 ± 0.04 | 0.93 ± 0.08 | 1.14 ± 0.09 |
Total fat pads, g | 38.0 ± 3.3a | 42.8 ± 3.8a | 70.4 ± 8.5b |
Total fat pad/carcass weight, % | 8.07 ± 0.45a | 9.88 ± 0.68a | 15.8 ± 0.9b |
Leptin, ng/ml | 11.2 ± 0.7a | 18.8 ± 2.3a | 39.6 ± 2.9b |
Glucose, mg/dl | 148 ± 4 | 152 ± 6 | 143 ± 3 |
Insulin, ng/ml | 1.75 ± 0.28a | 2.63 ± 0.46a,b | 3.66 ± 0.46b |
Glucose AUC, mg·dl−1·120 min−1 | 4,932 ± 813 | 4,643 ± 606 | 5,731 ± 764 |
Insulin AUC, mg·dl−1·120 min−1 | 87.9 ± 19.7a | 91.1 ± 17.7a | 204.1 ± 30.6b |
Insulin sensitivity index | 34.2 ± 5.2a | 30.9 ± 4.2a | 17.4 ± 2.5b |
Liver, g | 13.64 ± 1.08 | 12.80 ± 0.89 | 12.66 ± 0.68 |
Naso-anal length, cm | 24.8 ± 0.2 | 24.4 ± 0.4 | 23.6 ± 0.3 |
Values are means ± SE; n = 7 AAV control shRNA rats; n = 8 AAV CTR shRNA rats. Additional diet-resistant (DR) rats were sham-injected (n = 7). Rats were maintained on chow diet for 6 wk, followed by 6 wk on 45% fat diet.
VMH, ventromedial hypothalamus; AAV CTR shRNA, adeno-associated virus containing a short hairpin portion of the CTR mRNA; AAV, adeno-associated virus; BW, body weight; BWG, BW gain; FI, food intake; AUC, area under the curve.
Data for each parameter with differing superscripted letters differ from each other by P = 0.05 by post hoc Bonferroni test after intergroup differences were found by one-way ANOVA.